Erratum to "First-line ribociclib plus letrozole for postmenopausal women with HR+, HER2- ABC: MONALEESA-2 safety results" [Breast 36 (Suppl. 1) (November 2017) S44–S45]. (August 2018) - Janni, Wolfgang; Chan, Arlene; Nusch, Arnd; Alba, Emilio; Bachelot, Thomas; Gil-Gil, Miguel; Kattan, Joseph; Bourgeois, Hugues; El Karak, Fadi; Sutradhar, Santosh; Miller, Michelle; Chandiwana, David; et al.